CN3- COST-SAVINGS FOR CAPECITABINE DUE TO ORAL ADMINISTRATION IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER
Abstract
Authors
K Hieke C Twelves M Boyer M Findlay C Weitzel C Barker B Osterwalder C Jamieson
K Hieke C Twelves M Boyer M Findlay C Weitzel C Barker B Osterwalder C Jamieson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now